{"comparisonGroups":["Control","Immune Tolerant"],"dateCreated":"2025-09-26 00:00:00","display_title":"HBV: Control vs Immune Tolerant phase","group_a_title":"Control group with no HBV infection. Provides baseline metabolic profile for comparison with infected groups.","group_b_title":"Samples in the immune tolerant phase of HBV infection. Helps understand metabolic changes during the immune tolerant phase.","id":"MTBLS280_0006_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":5,"studyId":"MTBLS280","studyUrl":"http://integmet.org/study/MTBLS280","title":"Control_vs_Immune_Tolerant","topHits":[{"chebi_id":"57959","direction":"up","inn_name":"","iupac_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-azaniumyl-4-oxobutanoate","metabolite_id":"YGPSJZOEDVAXAB-QMMMGPOBSA-N","pvalue":4.72233803959192e-05,"ratio":1.7180768421509902,"synonym_name":"(2<i>S</i>)-4-(2-aminophenyl)-2-ammonio-4-oxobutanoate"},{"chebi_id":"16927","direction":"up","inn_name":"","iupac_name":"<em>N</em>-[(5<i>S</i>)-5-amino-5-carboxypentyl]-<small>L</small>-glutamic acid","metabolite_id":"ZDGJAHTZVHVLOT-YUMQZZPRSA-N","pvalue":0.0019861206248476,"ratio":1.6595665181261314,"synonym_name":"L-Saccharopine"},{"chebi_id":"73707","direction":"up","inn_name":"","iupac_name":"<small>L</small>-\u03b3-glutamyl-<small>L</small>-glutamine","metabolite_id":"JBFYFLXEJFQWMU-WDSKDSINSA-N","pvalue":0.002798025457996,"ratio":1.689870109010492,"synonym_name":"\u03b3-<small>L</small>-Glu-<small>L</small>-Gln"},{"chebi_id":"20392","direction":"down","inn_name":"","iupac_name":"4-hydroxyproline","metabolite_id":"PMMYEEVYMWASQN-UHFFFAOYSA-N","pvalue":0.0212344803187443,"ratio":0.5935793833607781,"synonym_name":"4Hyp"},{"chebi_id":"","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"IDIDJDIHTAOVLG-GSVOUGTGSA-N","pvalue":0.024713072876712,"ratio":0.6051787853290395,"synonym_name":""}],"totalFeatures":38}